Log in to your Inderes Free account to see all free content on this page.
Biotage
179.1 SEK -0.22%Be the first to follow this company
Biotage is active in biotechnology. The company provides solutions in chromatography, organic synthesis, and sample preparation. The company has operations on a global level, mainly concentrated in Europe, North America, and Asia, and a large part of the projects are also conducted in collaboration with other players in the said market. Customers are found in health and care, as well as in the food industry.
Revenue
1.86B
EBIT %
16.86 %
P/E
53.62
Dividend yield-%
0.89 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BIOT
Daily low / high price
176.8 / 181.8
SEK
Market cap
14.45B SEK
Turnover
9.44M SEK
Volume
53K
Latest videos
Financial calendar
Interim report
16.07.2024
Interim report
23.10.2024
Annual report
19.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gamma Biosciences | 16.9 % | 17.0 % |
SEB Fonder | 7.6 % | 7.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Resolutions at the Annual General Meeting in Biotage AB on April 25, 2024
Biotage AB (publ) Interim report January-March 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio